Loading...

Mitra K Nadim, FASN

TitleProfessor of Clinical Medicine
InstitutionUniversity of Southern California
DepartmentMedicine
AddressHCC II 1520 San Pablo St. Ste. 4225-C
Off Campus
Los Angeles CA 90089
Phone+1 323 226 7307
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    Golden Key National Honor Society1988Member
    University of California, Irvine1989Phi Beta Kappa
    University of California, Irvine1990Cum Laude
    University of California, Irvine1990Excellence in Research Award
    National Kidney Foundation1999Volunteer/Donor Award
    Alpha Omega Alpha1992Research Fellowship Award
    National Institutes of Health1999National Research Service Award
    Keck School of Medicine of USC2004Outstanding Year II Teaching Award
    Keck School of Medicine of USC2007Medical Faculty Women's Award Research Grant
    Keck School of Medicine of USC2007Outstanding Year II Teaching Award
    Rheos Pivitol Trial 2008National Principal Investigator
    Keck School of Medicine of USC2008Outstanding Year II Course Award
    Keck School of Medicine of USC2011Outstanding Year II Teaching Award
    Keck School of Medicine of USC2011Master Teacher Award
    Keck School of Medicine2012Faculty Teaching Award
    Keck School of Medicine of USC2013Outstanding Year II Course Award
    Keck School of Medicine of USC2015Faculty Teaching Award

    Collapse Overview 
    Collapse Overview
    After graduating from UCLA Medical School, Dr. Nadim went to Boston for her internship and residency at the prestigious Beth Israel Hospital, which is affiliated with Harvard University’s School of Medicine. After completing a nephrology fellowship at Brigham and Women’s/Massachusetts General Hospital, Harvard University, Dr. Nadim returned to Southern California and currently serves as Professor of Clinical Medicine and Director of USC’s Hypertension Center. Dr. Nadim served as the Associate Program Director for the Nephrology Fellowship Program from 2003 – 2006.

    Dr. Nadim’s major clinical and research interests concerns the diagnosis and management of resistant hypertension. she is currently one of the National Principal Investigators in the Rheos Pivitol Trial, which is a multicenter clinical trial looking at efficacy and safety of the Rheos system, an implantable baroreflex device, in subjects with resistant hypertension.

    Dr. Nadim's clinical areas of expertise:

    HYPERTENSION CLINIC

    Dr. Nadim is a clinical specialist in hypertension and Director of the USC Hypertension Center. She has been an investigator in several hypertension studies, and her clinical practice has a special emphasis on resistant hypertension.


    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Nadim MK, Forni LG, Bihorac A, Hobson C, Koyner JL, Shaw A, Arnaoutakis GJ, Ding X, Engelman DT, Gasparovic H, Gasparovic V, Herzog CA, Kashani K, Katz N, Liu KD, Mehta RL, Ostermann M, Pannu N, Pickkers P, Price S, Ricci Z, Rich JB, Sajja LR, Weaver FA, Zarbock A, Ronco C, Kellum JA. Cardiac and Vascular Surgery-Associated Acute Kidney Injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group. J Am Heart Assoc. 2018 Jun 01; 7(11). PMID: 29858368.
      View in: PubMed
    2. Durand F, Francoz C, Asrani SK, Khemichian S, Pham TA, Sung RS, Genyk YS, Nadim MK. Acute Kidney Injury after Liver Transplantation. Transplantation. 2018 May 29. PMID: 29847502.
      View in: PubMed
    3. Durand F, Olson JC, Nadim MK. Renal dysfunction and cirrhosis. Curr Opin Crit Care. 2017 Dec; 23(6):457-462. PMID: 29023314.
      View in: PubMed
    4. Nadim MK, DiNorcia J, Ji L, Groshen S, Levitsky J, Sung RS, Kim WR, Andreoni K, Mulligan D, Genyk YS. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease. J Hepatol. 2017 Sep; 67(3):517-525. PMID: 28483678.
      View in: PubMed
    5. de Leeuw PW, Bisognano JD, Bakris GL, Nadim MK, Haller H, Kroon AA. Sustained Reduction of Blood Pressure With Baroreceptor Activation Therapy: Results of the 6-Year Open Follow-Up. Hypertension. 2017 May; 69(5):836-843. PMID: 28320856.
      View in: PubMed
    6. Kellum JA, Zarbock A, Nadim MK. What endpoints should be used for clinical studies in acute kidney injury? Intensive Care Med. 2017 06; 43(6):901-903. PMID: 28255614.
      View in: PubMed
    7. Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM, Bittleman D, Cruz D, Endre Z, Fitzgerald RL, Forni L, Kane-Gill SL, Hoste E, Koyner J, Liu KD, Macedo E, Mehta R, Murray P, Nadim M, Ostermann M, Palevsky PM, Pannu N, Rosner M, Wald R, Zarbock A, Ronco C, Kellum JA. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017 04; 13(4):241-257. PMID: 28239173.
      View in: PubMed
    8. DiNorcia J, Meouchy J, Genyk YS, Nadim MK. Perioperative Renal Replacement Therapy in Liver Transplantation. Int Anesthesiol Clin. 2017; 55(2):81-91. PMID: 28225534.
      View in: PubMed
    9. Wachter R, Halbach M, Bakris GL, Bisognano JD, Haller H, Beige J, Kroon AA, Nadim MK, Lovett EG, Schafer JE, de Leeuw PW. An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems. J Am Soc Hypertens. 2017 Feb; 11(2):81-91. PMID: 28065708.
      View in: PubMed
    10. Nadim MK, Durand F, Kellum JA, Levitsky J, O'Leary JG, Karvellas CJ, Bajaj JS, Davenport A, Jalan R, Angeli P, Caldwell SH, Fernández J, Francoz C, Garcia-Tsao G, Ginès P, Ison MG, Kramer DJ, Mehta RL, Moreau R, Mulligan D, Olson JC, Pomfret EA, Senzolo M, Steadman RH, Subramanian RM, Vincent JL, Genyk YS. Corrigendum to "Management of the critically ill patients with cirrhosis: A multidisciplinary perspective". J Hepatol. 2016 May 27. PMID: 27241199.
      View in: PubMed
    11. Francoz C, Nadim MK, Durand F. Kidney biomarkers in cirrhosis. J Hepatol. 2016 Oct; 65(4):809-824. PMID: 27238754.
      View in: PubMed
    12. Durand F, Nadim MK. Management of Acute-on-Chronic Liver Failure. Semin Liver Dis. 2016 05; 36(2):141-52. PMID: 27172356.
      View in: PubMed
    13. Nadim MK, Durand F, Kellum JA, Levitsky J, O'Leary JG, Karvellas CJ, Bajaj JS, Davenport A, Jalan R, Angeli P, Caldwell SH, Fernández J, Francoz C, Garcia-Tsao G, Ginès P, Ison MG, Kramer DJ, Mehta RL, Moreau R, Mulligan D, Olson JC, Pomfret EA, Senzolo M, Steadman RH, Subramanian RM, Vincent JL, Genyk YS. Management of the critically ill patient with cirrhosis: A multidisciplinary perspective. J Hepatol. 2016 Mar; 64(3):717-35. PMID: 26519602.
      View in: PubMed
    14. Durand F, Graupera I, Ginès P, Olson JC, Nadim MK. Pathogenesis of Hepatorenal Syndrome: Implications for Therapy. Am J Kidney Dis. 2016 Feb; 67(2):318-28. PMID: 26500178.
      View in: PubMed
    15. Karvellas CJ, Durand F, Nadim MK. Acute Kidney Injury in Cirrhosis. Crit Care Clin. 2015 Oct; 31(4):737-50. PMID: 26410141.
      View in: PubMed
    16. Al-Khafaji A, Nadim MK, Kellum JA. Hepatorenal Disorders. Chest. 2015 Aug; 148(2):550-558. PMID: 25811649.
      View in: PubMed
    17. Fong MW, Shavelle D, Weaver FA, Nadim MK. Renal Denervation in Heart Failure. Curr Hypertens Rep. 2015 Mar; 17(3):17. PMID: 25754320.
      View in: PubMed
    18. Ghofrani H, Weaver FA, Nadim MK. Resistant hypertension: medical management and alternative therapies. Cardiol Clin. 2015 Feb; 33(1):75-87. PMID: 25439332.
      View in: PubMed
    19. Nadim MK, Annanthapanyasut W, Matsuoka L, Appachu K, Boyajian M, Ji L, Sedra A, Genyk YS. Intraoperative hemodialysis during liver transplantation: a decade of experience. Liver Transpl. 2014 Jul; 20(7):756-64. PMID: 24634344.
      View in: PubMed
    20. Francoz C, Nadim MK, Baron A, Prié D, Antoine C, Belghiti J, Valla D, Moreau R, Durand F. Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations. Hepatology. 2014 Apr; 59(4):1514-21. PMID: 24037821.
      View in: PubMed
    21. Nadim MK, Sung RS. Living donor liver transplantation for hepatorenal syndrome: to do or not to do? That is the question. Liver Transpl. 2012 Oct; 18(10):1138-9. PMID: 22740330.
      View in: PubMed
    22. Nadim MK, Sung RS, Davis CL, Andreoni KA, Biggins SW, Danovitch GM, Feng S, Friedewald JJ, Hong JC, Kellum JA, Kim WR, Lake JR, Melton LB, Pomfret EA, Saab S, Genyk YS. Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant. 2012 Nov; 12(11):2901-8. PMID: 22822723.
      View in: PubMed
    23. Nadim MK, Davis CL, Sung R, Kellum JA, Genyk YS. Simultaneous liver-kidney transplantation: a survey of US transplant centers. Am J Transplant. 2012 Nov; 12(11):3119-27. PMID: 22759208.
      View in: PubMed
    24. Nadim MK, Genyk YS, Tokin C, Fieber J, Ananthapanyasut W, Ye W, Selby R. Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome. Liver Transpl. 2012 May; 18(5):539-48. PMID: 22250075.
      View in: PubMed
    25. Bakris GL, Nadim MK, Haller H, Lovett EG, Schafer JE, Bisognano JD. Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial. J Am Soc Hypertens. 2012 Mar-Apr; 6(2):152-8. PMID: 22341199.
      View in: PubMed
    26. Nadim MK, Kellum JA, Davenport A, Wong F, Davis C, Pannu N, Tolwani A, Bellomo R, Genyk YS. Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2012 Feb 09; 16(1):R23. PMID: 22322077; PMCID: PMC3396267.
    27. Davenport A, Ahmad J, Al-Khafaji A, Kellum JA, Genyk YS, Nadim MK. Medical management of hepatorenal syndrome. Nephrol Dial Transplant. 2012 Jan; 27(1):34-41. PMID: 22287700.
      View in: PubMed
    28. Bisognano JD, Bakris G, Nadim MK, Sanchez L, Kroon AA, Schafer J, de Leeuw PW, Sica DA. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol. 2011 Aug 09; 58(7):765-73. PMID: 21816315.
      View in: PubMed
    29. Wong F, Nadim MK, Kellum JA, Salerno F, Bellomo R, Gerbes A, Angeli P, Moreau R, Davenport A, Jalan R, Ronco C, Genyk Y, Arroyo V. Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut. 2011 May; 60(5):702-9. PMID: 21325171.
      View in: PubMed
    30. Tokin C, Almeda J, Jain S, Kim J, Henderson R, Nadim M, Sher L, Selby RR. Blood-management programs: a clinical and administrative model with program implementation strategies. Perm J. 2009; 13(1):18-28. PMID: 21373242; PMCID: PMC3034461.
    31. Pannu N, Nadim MK. An overview of drug-induced acute kidney injury. Crit Care Med. 2008 Apr; 36(4 Suppl):S216-23. PMID: 18382197.
      View in: PubMed
    32. Campese VM, Nadim MK, Epstein M. Are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors renoprotective? J Am Soc Nephrol. 2005 Mar; 16 Suppl 1:S11-7. PMID: 15938026.
      View in: PubMed
    33. Nadim MK, Dua R, Campese VM. Antihypertensive drugs and the kidney. Curr Cardiol Rep. 2004 Nov; 6(6):403-8. PMID: 15485598.
      View in: PubMed